About Brilliant Bio Pharma Private Limited
Data last updated: 11 January 2026
Brilliant Bio Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in animal pharmaceuticals and healthcare, a part of the broader pharmaceuticals sector. Incorporated on 11 March 2010, the company has been in operation for over 16 years.
Registered with ROC Hyderabad under CIN U24100AP2010PTC067485.
Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.71 Cr. Formerly known as Brilliant Industries Limited. and Brilliant Bio Pharma Limited. It is led by directors including Shukacharya Manur and Hari Narayana Goluguri Reddy.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Vth Floor T.G.V. Mansion 6 – 2 – 1012 Rajbhavan Road Khairatabad, Hyderabad, Telangana, India – 500004.
As per the financials filed for FY 2025, the company reported a revenue of ₹174.32 Cr, a growth of 85% compared to the previous year.
The company has a workforce of approximately 163 employees as per the latest available data.
The company is associated with 1 brand - Brilliant Bio Pharma. As per MCA filings, the company has open charges of ₹65.36 Cr and satisfied charges of ₹15.11 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brilliantbiopharma.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressVth Floor T.G.V. Mansion 6 – 2 – 1012 Rajbhavan Road Khairatabad, Hyderabad, Telangana, India – 500004
-
IndustryPharma, Animal Pharmaceuticals & Healthcare
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Brilliant Bio Pharma Private Limited
Brilliant Bio Pharma Private Limited has undergone 2 name changes throughout its history. The company was previously known as Brilliant Industries Limited., and Brilliant Bio Pharma Limited. The current legal name is Brilliant Bio Pharma Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Brilliant Bio Pharma Private Limited | Current |
| Brilliant Industries Limited. | Previous |
| Brilliant Bio Pharma Limited | Previous |
CIN History of Brilliant Bio Pharma Private Limited
Brilliant Bio Pharma Private Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG2010PTC067485, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2010PTC067485 | Current |
| U24100AP2010PTC067485 | Previous |
| U24100AP2010PLC067485 | Previous |
| U74999AP2010PLC067485 | Previous |
Associated Brands with Brilliant Bio Pharma Private Limited
Brilliant Bio Pharma Private Limited operates one associated brand: Brilliant Bio Pharma. These brands represent Brilliant Bio Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Veterinary vaccine manufacturing services are provided to clients. | brilliantbiopharma.com |
Business Activity of Brilliant Bio Pharma Private Limited
Brilliant Bio Pharma Private Limited is engaged in principal business activities including manufacturing and electricity, gas, steam and air condition supply, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, electric power generation, transmission and distribution. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
| D | Electricity, gas, steam and air condition supply | D1 | Electric power generation, transmission and distribution | ********* |
Board of Directors of Brilliant Bio Pharma Private Limited
Brilliant Bio Pharma Private Limited is currently managed by 5 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shukacharya Manur | Additional Director | 19 Aug 2020 | 5 Years 10 Months | Current |
| Hari Narayana Goluguri Reddy | Whole-Time Director | 10 Jun 2013 | 13 Years 1 Months | Current |
| Bobba Venu Gopal Rao | Additional Director | 19 Dec 2025 | 0 Years 6 Months | Current |
Financials of Brilliant Bio Pharma Private Limited FY 2025 filings available
Brilliant Bio Pharma Private Limited reported revenue of ₹174.32 Cr (up 85% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Brilliant Bio Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2023 | State Bank of India | ₹1.13 Cr | Open |
| 15 Jul 2013 | State Bank of India | ₹64.23 Cr | Open |
| 22 Apr 2022 | State Bank of India | ₹4.98 Cr | Satisfied |
| 15 Jan 2021 | State Bank of India | ₹10.13 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Brilliant Bio Pharma Private Limited
View historical data on people associated with Brilliant Bio Pharma Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Brilliant Bio Pharma Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Brilliant Bio Pharma Private Limited
GSTIN & GST Filing Data of Brilliant Bio Pharma Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Brilliant Bio Pharma Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Brilliant Bio Pharma Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Brilliant Bio Pharma Private Limited
MSME Payment Delays by Brilliant Bio Pharma Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Brilliant Bio Pharma Private Limited
Subsidiaries & Group Companies of Brilliant Bio Pharma Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Brilliant Bio Pharma Private Limited with ownership details.
MCA Filings & Documents of Brilliant Bio Pharma Private Limited
MCA Filings & Documents of Brilliant Bio Pharma Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Brilliant Bio Pharma Private Limited
Recent News on Brilliant Bio Pharma Private Limited
Frequently Asked Questions about Brilliant Bio Pharma Private Limited
Brilliant Bio Pharma Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 11 March 2010 (16+ years old) and is registered under CIN U24100TG2010PTC067485. The company has 163 employees.
Brilliant Bio Pharma Private Limited reported revenue of ₹174.32 Cr for FY 2025 (up 85.00% YoY).
The current directors of Brilliant Bio Pharma Private Limited are:
- Shukacharya Manur
- Hari Narayana Goluguri Reddy
- Mourya Boda
- Suchita Choraria
- Bobba Venu Gopal Rao
The primary industry of Brilliant Bio Pharma Private Limited is pharma. The company specifically operates in animal pharmaceuticals and healthcare. The company is currently active in this sector.
Brilliant Bio Pharma Private Limited can be reached at the registered office: Vth Floor T.G.V. Mansion 6 – 2 – 1012 Rajbhavan Road Khairatabad, Hyderabad, Telangana, India – 500004, or through the website brilliantbiopharma.com.
The authorised capital is ₹15 Cr, and the paid-up capital is ₹12.71 Cr.